Biotech

All Articles

Orion to utilize Aitia's 'digital doubles' to find brand-new cancer cells medications

.Finnish biotech Orion has spied potential in Aitia's "digital identical twin" specialist to establi...

Windtree's shock med increases blood pressure in most recent period 2 win

.While Windtree Therapies has actually had a hard time to increase the monetary roots needed to surv...

2 cancer cells biotechs combine, generating global footprint

.OncoC4 is taking AcroImmune-- and its internal scientific production functionalities-- under its ow...

Amgen records first period 3 gain for $400M chronic eczema medicine

.Amgen has actually shared (PDF) the initial period 3 records on its $400 million dermatitis medicin...

Biogen, UCB file period 3 lupus win after falling short earlier test

.Biogen as well as UCB's gamble on improving into period 3 astride a broken study seeks to have paid...

Aptadir hopes brand new RNA preventions can turn around complicated cancers

.Italian biotech Aptadir Therapies has actually released along with the assurance that its own pipel...

Wave surfs DMD success to regulatory authorities' doors, sending stockpile

.Wave Lifestyle Sciences has satisfied its goal in a Duchenne muscular dystrophy (DMD) study, positi...

Sanofi plucks new CSO from in-stealth biotech

.After a couple of years in biotech, Mike Quigley, Ph.D., is going back to the pharma layer, taking ...

Achilles drops tissue treatment system, prepares for discharges after skipping 'business viability' goals

.Achilles Therapeutics has actually torn up its tactic. The British biotech is actually knocking off...

Aligos advertises stage 2 MASH succeed, lowering liver fat approximately 46%

.Aligos Rehabs is actually advertising a midstage win in metabolic-dysfunction associated steatohepa...